Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep;34(5):e15085.
doi: 10.1111/dth.15085. Epub 2021 Aug 10.

Onset/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two cases

Prateek Nagrani  1 , Rashmi Jindal  1 , Dikshita Goyal  1
Affiliations
Case Reports

Onset/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two cases

Prateek Nagrani et al. Dermatol Ther. 2021 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare there is no potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
A 56‐year‐old lady with psoriasis exacerbation post‐Covid‐19 vaccination (A), Histopathology revealing parakeratosis, Munro's microabscesses and psoriasiform hyperplasia (H&EX10) (C), Significant improvement after 1 week (E). A 65‐year‐old man with new‐onset psoriasis Vulgaris 10 days post‐Covid‐19 vaccination (B), Histopathology revealing parakeratosis, Munro's microabscesses and psoriasiform hyperplasia (H&EX10) (D), Improvement after 1 week (F)
See this image and copyright information in PMC

References

    1. Ministry of Health and Family Welfare , Government of India. COVID‐19 vaccine faqs. 2021.
    1. Serum Institute of India . Covishield faqs. 2021.
    1. Bogdanov G, Bogdanov I, Kazandjieva J, Tsankov N. Cutaneous adverse effects of the available COVID‐19 vaccines. Clin Dermatol. 2021. 10.1016/j.clindermatol.2021.04.001. - DOI - PMC - PubMed
    1. ChAdOx1 nCoV‐19 Corona Virus Vaccine (Recombinant) : Covishield product monograph. 2021.
    1. Ewer KJ, Barrett JR, Belij‐Rammerstorfer S, et al. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV‐19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med. 2021;27:270‐278. - PubMed